VitaNova Life Sciences (VNOV) Receivables (2024 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Receivables came in at $788109.0 in Q2 2026, up 4.53% YoY from $753971.0 in Q2 2025, and down 5.29% on a QoQ basis from $832132.0 in Q1 2026.
VitaNova Life Sciences (VNOV) Receivables (2024 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 3 years of Receivables data on file, last reported at $788109.0 in Q2 2026.
- Quarterly Receivables rose 4.53% year-over-year to $788109.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $788109.0 (up 4.53% YoY) and the FY2026 annual result came in at $629307.0, down 34.78% from the prior year.
- Receivables declined to $788109.0 in Q2 2026, from $832132.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.0 million in Q3 2025 to a low of -$110780.0 in Q4 2024.
- A 3-year average of $586090.2 and a median of $771040.0 in 2025 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 1440.47% in 2026, down 4.53% in 2026.
- Tracing VNOV's Receivables over 3 years: stood at -$110780.0 in 2024, then surged by 908.92% to $896120.0 in 2025, then fell by 12.05% to $788109.0 in 2026.
- The last three Receivables figures came in at $788109.0 (Q2 2026), $832132.0 (Q1 2026), and $896120.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 30.32 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 25.45 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 13.82 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 1.79 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 193.81 Mn |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 12.25 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 120.08 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 27.28 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 22.44 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 788,109.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 788,109.00 |
| Jan 31, 2026 | 832,132.00 |
| Oct 31, 2025 | 896,120.00 |
| Jul 31, 2025 | 1.01 Mn |
| Apr 30, 2025 | 753,971.00 |
| Jan 31, 2025 | 54,018.00 |
| Oct 31, 2024 | -110,780.00 |
| Apr 30, 2024 | 460,870.00 |